Doctor profile · Federal record
Dr. Alina Gerasymova, PA-C
Physician Assistant · Procedural Dermatology Physician · Rockville, MD
- NPI 1205347994
- Accepts Medicare
- MIPS 83.3 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
15245 Shady Grove RD Ste 370
Rockville, MD 208506237
(240) 246-7417
fax (240) 477-4364
Credentials & registration
- NPI registered
- October 2017 — 9 yrs on file
- Profile last updated
- January 5, 2026
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Maryland #C06647 · Maryland #C0006647
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1205347994. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,831
Distinct HCPCS
10
Medicare allowed
$203,406
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,562 | 361 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 841 | 534 | $81 | |
17000 |
Destruction of precancer skin growth, 1 growth | 651 | 396 | $53 | |
17110 |
Destruction of skin growth, 1-14 growths | 243 | 184 | $104 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 139 | 112 | $114 | |
11102 |
Biopsy of related skin growth, first growth | 113 | 92 | $86 | |
11401 |
Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | 68 | 33 | $108 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 43 | 43 | $101 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 39 | 33 | $155 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 30 | 28 | $51 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 106. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$1,315
Transactions
34
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Galderma Laboratories, L.P. | 4 | $317.25 | |
| Janssen Biotech, Inc. | 5 | $269.22 | |
| Lilly USA, LLC | 5 | $160.30 | |
| Dermavant Sciences, Inc. | 7 | $158.72 | |
| Verrica Pharmaceuticals Inc. | 1 | $81.69 | |
| GENZYME CORPORATION | 4 | $76.82 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $73.50 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61.74 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $42.99 | |
| ABBVIE INC. | 1 | $32.98 | |
| UCB, Inc. | 1 | $24.56 | |
| Arcutis Biotherapeutics, Inc. | 1 | $15.39 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
301
Patients
193
Total drug cost
$10,091
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 55 | 34 | $587 |
| Fluocinonide | Generic | 45 | 31 | $2,630 |
| Ketoconazole | Generic | 43 | 29 | $1,035 |
| Mupirocin | Generic | 28 | 20 | $377 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 24 | 15 | $555 |
| Metronidazole | Generic | 23 | 18 | $1,637 |
| Hydrocortisone | Generic | 21 | 18 | $108 |
| Cephalexin | Generic | 18 | 15 | $896 |
| Clotrimazole-Betamethasone (Clotrimazole/Betamethasone Dip) | Brand | 15 | 13 | $436 |
| Doxycycline Hyclate | Generic | 15 | 0 | $887 |
Frequently asked questions
What is Dr. Alina Gerasymova's medical specialty?
Dr. Alina Gerasymova practices Physician Assistant in Rockville, MD.
Where does Dr. Alina Gerasymova practice?
Dr. Alina Gerasymova practices at 15245 Shady Grove RD Ste 370, Rockville, MD 208506237. Office phone: 2402467417.
What is Dr. Alina Gerasymova's NPI?
Dr. Alina Gerasymova's National Provider Identifier (NPI) is 1205347994, issued by NPPES.
Does Dr. Alina Gerasymova accept Medicare assignment?
Yes. Dr. Alina Gerasymova accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alina Gerasymova commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.